Summary by Futu AI
KOCHI PHARMACEUTICAL-B (02171.HK) FILED ITS LATEST SECURITIES CHANGE MONTH REPORT WITH HONG KONG TRADING AND SETTLEMENT LIMITED ON APRIL 8, 2024, REPORTING THE CHANGES IN COMPANY SHARES FOR THE YEAR ENDED MARCH 31, 2024. THE REPORT SHOWS THAT THE COMPANY'S STATUTORY/REGISTERED SHARE CAPITAL WAS UNCHANGED AT 200,000,000,000 SHARES WITH A FACE VALUE OF $0.000025 PER SHARE FOR A TOTAL OF $50,000. In addition, under the 2019 Stock Incentive Program and the Initial Public Offering Post-IPO Share Option Plan, the Company issued no additional shares during the month, but 225,481 share options expired. As of the end of the reporting period, the number of new shares that may be issued under the Equity Incentive Scheme in 2019 is 3,798,492 shares. The Company confirms that all securities issued this month have been authorized by the Board of Directors and comply with the relevant requirements of the Securities Listing Rules of the Hong Kong Stock Exchange Limited.